Latest On Elekta AB (publ) (EKTAY):
About Elekta AB (publ) (EKTAY):
Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems. In addition, the company offers radiosurgery systems under the Leksell Gamma Knife Icon, Leksell Gamma Knife Perfexion, and Elekta Axesse names; Leksell GammaPlan, a treatment planning software; and Elekta Unity, a magnetic resonance radiation therapy solution. Further, it provides care management software, such as MOSAIQ Radiation Oncology and MOSAIQ Medical Oncology; MOSAIQ IQ Scripts, a workflow automation and customization tool; Patient Engagement, a patient communication tool; MOSAIQ Evaluate, a plan management and dose review solution; MOSAIQ Locate, a stereotactic localization solution; and METRIQ, a cancer registry data management solution. Additionally, the company offers Flexitron, a remote after loading platform; Esteya, an electronic brachytherapy for treating skin cancer; Oncentra Brachy, a treatment planning software; real-time prostate solutions; and gynecological brachytherapy, bronchus and esophagus, breast, prostate, rectum and bladder, and skin applicators, as well as brachytherapy needles and flexible implant tubes. It also provides Leksell Vantage Stereotactic System for neuroimaging and treatment; Leksell Stereotactic System for minimally invasive stereotactic neurosurgery; and proton therapy components. The company was founded in 1972 and is headquartered in Stockholm, Sweden.
General
- Name Elekta AB (publ)
- Symbol EKTAY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 4,000
- Last Split Factor4:1
- Last Split Date2012-09-25
- Fiscal Year EndApril
- Web URLhttp://www.elekta.com
Valuation
- Trailing PE 42.24
- Forward PE 24.75
- Price/Sales (Trailing 12 Mt.) 3.03
- Price/Book (Most Recent Quarter) 5.2
- Enterprise Value Revenue 0.39
- Enterprise Value EBITDA 1.8
Financials
- Most Recent Quarter 2021-01-31
- Profit Margin 9%
- Return on Assets 5%
- Return on Equity 16%
- Earnings Per Share $0.31
- Revenue Per Share $0
- Gross Profit 6.14 billion
- Quarterly Earnings Growth -2.1%
Highlights
- Market Capitalization 4.94 billion
- PEG Ratio 1.09
- Book Value Per Share $2.05
Share Statistics
- Shares Outstanding 382.08 million
- Shares Float 358.16 million
- % Held by Insiders <1%
- % Held by Institutions 0.02%
Technicals
- Beta 0.61
- 52 Week High $15.19
- 52 Week Low $6.2
- 50 Day Moving Average 14.04
- 200 Day Moving Average 13.26
Dividends
- Forward Annual Dividend Rate $0.21
- Forward Annual Dividend Yield 1.52%
- Payout Ratio 27%
- Dividend Date 2020-09-17
- ExDividend Date 2020-08-27
- Dividend Per Share $0.16
- Dividend Yield 0%
Elekta AB (publ) (EKTAY) Dividend Calendar:
EKTAY's last dividend payment was made to shareholders on September 17, 2020.
Elekta AB (publ) pays out 27% of its earnings out as a dividend.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Elekta AB (publ) (EKTAY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2021-01-31 | 2021-01-31 | $3.58 billion | $0.10 | ||
2020-10-31 | 2021-01-31 | $3.53 billion | $0.10 | ||
2020-07-31 | 2020-10-31 | $N/A | $0.11 | $0.28 | -60.68% |
2020-04-30 | 2020-07-31 | $N/A | $0.06 | $1.05 | -93.87% |
2020-01-31 | 2020-04-30 | $3.66 billion | $0.11 | $0.74 | -85.22% |
2019-10-31 | 2020-01-31 | $3.71 billion | $0.08 | $0.68 | -87.69% |
2019-07-31 | 2019-10-31 | $3.23 billion | $0.06 | $0.39 | -84.64% |
2019-04-30 | 2019-07-31 | $4.09 billion | $0.04 | $1.45 | -97.29% |
2019-01-31 | 2019-04-30 | $3.32 billion | $0.15 | $0.81 | -81.8% |
2018-10-31 | 2019-01-31 | $3.33 billion | $0.06 | $0.96 | -93.67% |
2018-07-31 | 2018-10-31 | $2.82 billion | $0.08 | $0.47 | -82.55% |
2018-04-30 | 2018-07-31 | $3.65 billion | $0.05 | $1.61 | -96.96% |
2018-01-31 | 2018-04-30 | $2.95 billion | $0.15 | $0.62 | -75.85% |
2017-10-31 | 2018-01-31 | $2.8 billion | $0.11 | $0.46 | -75.17% |
2017-07-31 | 2017-10-31 | $2.17 billion | $0.10 | $0.12 | -20.33% |
2017-04-30 | 2017-07-31 | $3.72 billion | $0.06 | $1.84 | -96.5% |
2017-01-31 | 2017-04-30 | $2.67 billion | $0.03 | $0.56 | -95.16% |
2016-10-31 | 2017-01-31 | $0.01 | $0.46 | -97.26% | |
2016-07-31 | 2016-10-31 | $0.02 | -$0.10 | 115.5% | |
2016-04-30 | 2016-07-31 | -$0.02 | $1.48 | -101.34% | |
2016-01-31 | 2016-04-30 | $0.02 | $0.54 | -95.39% | |
2015-10-31 | 2016-01-31 | $0.00 | $0.41 | -99.71% | |
2015-07-31 | 2015-10-31 | $0.06 | -$0.12 | 148.08% | |
2015-04-30 | 2015-07-31 | -$0.04 | $1.55 | -102.58% | |
2015-01-31 | 2015-04-30 | $0.11 | $0.80 | -86.54% | |
2014-10-31 | 2015-01-31 | $0.05 | $0.67 | -92.97% | |
2014-07-31 | 2014-10-31 | $0.07 | $0.14 | -49.79% | |
2014-04-30 | 2014-07-31 | -$0.05 | $2.44 | -102.14% | |
2014-01-31 | 2014-04-30 | $0.33 | $0.13 | 152.92% | |
2013-10-31 | 2014-01-31 | $0.06 | $0.13 | -54.08% | |
2013-07-31 | 2013-10-31 | $0.08 | |||
2013-04-30 | 2013-07-31 | $-0.00 | |||
2013-01-31 | 2013-04-30 | $0.34 | |||
2012-10-31 | 2013-01-31 | $0.09 | |||
2012-07-31 | 2012-10-31 | $0.10 | |||
2012-04-30 | 2012-07-31 | $0.00 | |||
2012-01-31 | 2012-04-30 | $0.21 | |||
2011-10-31 | 2012-01-31 | $0.15 | |||
2011-07-31 | 2011-10-31 | $0.10 | |||
2011-04-30 | 2011-07-31 | $0.02 | |||
2011-01-31 | 2011-04-30 | $0.23 | |||
2010-10-31 | 2011-01-31 | $0.08 | |||
2010-07-31 | 2010-07-31 | $0.04 | |||
2010-04-30 | 2010-04-30 | $0.18 | |||
2010-01-31 | 2010-01-31 | $0.06 | |||
2009-10-31 | 2009-10-31 | $0.06 | |||
2009-07-31 | 2009-07-31 | $0.02 | |||
2009-04-30 | 2009-04-30 | $0.12 |
Elekta AB (publ) (EKTAY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Jan 31 2021 | Oct 31 2020 | Jul 31 2020 | May 31 2020 | Apr 30 2020 |
---|---|---|---|---|---|
Research Development | 379 million | 377 million | N/A | 386 million | N/A |
Income Before Tax | 420 million | 490 million | N/A | 282 million | N/A |
Selling General Administrative | 534 million | 538 million | N/A | 551 million | N/A |
Gross Profit | 1.39 billion | 1.45 billion | N/A | 1.37 billion | N/A |
Ebit | 748 million | 803 million | N/A | 706 million | N/A |
Operating Income | 456 million | 515 million | N/A | 390 million | N/A |
Income Tax Expense | 99 million | 115 million | 66 million | 66 million | 173 million |
Total Revenue | 3.58 billion | 3.53 billion | N/A | 2.98 billion | N/A |
Cost of Revenue | 2.19 billion | 2.09 billion | N/A | 1.61 billion | N/A |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
Net Income From Continuing Operations | 321 million | 375 million | N/A | 216 million | N/A |
Net Income Applicable to Common Shares | 322 million | 375 million | 216 million | 216 million | 407 million |
Cash Flow:
Date | Oct 31 2020 | Jul 31 2020 | May 31 2020 | Apr 30 2020 | Feb 29 2020 |
---|---|---|---|---|---|
Investments | -181 million | N/A | -350 million | N/A | -263 million |
Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
Total Cash Flow from Investing Activities | N/A | -350 million | -350 million | -263 million | -263 million |
Net Borrowings | N/A | N/A | N/A | N/A | 3.31 billion |
Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
Change to Operating Activities | N/A | -102 million | -102 million | -305 million | -305 million |
Change in Cash | -2.08 billion | N/A | -193 million | N/A | 4.08 billion |
Total Cash from Operating Activities | 535 million | 211 million | 211 million | 1.24 billion | 1.24 billion |
Depreciation | 288 million | N/A | 316 million | N/A | 350 million |
Other Cash Flow from Investing Activities | N/A | N/A | -35 million | -23 million | 174 million |
Change to Inventory | 111 million | N/A | 7 million | N/A | 163 million |
Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
Other Cash Flow from Financing Activities | N/A | -54 million | -54 million | 3.45 billion | 137 million |
Change to Net Income | N/A | -2 million | -2 million | 216 million | 215 million |
Capital Expenditures | 145 million | N/A | 150 million | N/A | 391 million |
Balance Sheet:
Date | Jan 31 2021 | Oct 31 2020 | Jul 31 2020 | May 31 2020 | Apr 30 2020 |
---|---|---|---|---|---|
Total Liabailities | 17.25 billion | 17.5 billion | N/A | N/A | N/A |
Total Stockholder Equity | 8.21 billion | 8 billion | N/A | N/A | N/A |
Other Current Liabilities | 6.85 billion | 1.1 billion | N/A | 7.83 billion | N/A |
Total Assets | 25.46 billion | 25.5 billion | N/A | N/A | N/A |
Common Stock | 8.21 billion | N/A | 7.83 billion | 1.05 billion | 8.11 billion |
Other Current Assets | N/A | -1000000 | N/A | 7.83 billion | N/A |
Retained Earnings | N/A | N/A | N/A | N/A | N/A |
Other Liabilities | 911 million | N/A | 865 million | 865 million | 853 million |
Other Assets | 447 million | N/A | 492 million | 492 million | 504 million |
Cash | 4.64 billion | 3.91 billion | N/A | 5.85 billion | N/A |
Total Current Liabilities | 10.54 billion | 10.7 billion | N/A | 10.25 billion | N/A |
Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
Property, Plant & Equipment | 1.8 billion | N/A | 1.89 billion | 1.89 billion | 2.12 billion |
Total Current Assets | 13.92 billion | 13.21 billion | N/A | 14.65 billion | N/A |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | -523 million | N/A | -1.16 billion | -1.16 billion | -1.36 billion |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | 4.95 billion | 4.98 billion | N/A | 6.95 billion | N/A |
Inventory | 2.42 billion | 2.46 billion | N/A | 2.52 billion | N/A |
Accounts Payable | 947 million | 987 million | N/A | 784 million | N/A |
Elekta AB (publ) (EKTAY) Chart:
Elekta AB (publ) (EKTAY) News:
Below you will find a list of latest news for Elekta AB (publ) (EKTAY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Elekta AB (publ) (EKTAY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Elekta AB (publ) (EKTAY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2008-12-03 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1451160/000101915508000976/0001019155-08-000976-index.htm |
2013-02-15 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1451160/000119380513000509/0001193805-13-000509-index.htm |
2013-03-27 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1451160/000119380513000714/0001193805-13-000714-index.htm |
2013-08-19 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1451160/000119380513001491/0001193805-13-001491-index.htm |
2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1451160/000119380517003074/0001193805-17-003074-index.htm |
2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1451160/000119380519001771/0001193805-19-001771-index.htm |
2014-10-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1451160/000157104914005331/0001571049-14-005331-index.htm |